Paper33005103
Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer.
Rong J and 9 others. Cancer Cell Int, 2020. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer. Papers, record 33005103. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33005103
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29683340 | Let's fight cancer: let-7 is a tool to enhance antitumor immune responses. | Future Oncol | 2018 | https://conductscience.org/library/papers/29683340 | PubMed |
| 2 | 29660014 | IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29660014 | PubMed |
| 3 | 29616104 | High density of CD68+ tumor-associated macrophages predicts a poor prognosis in gastric cancer mediated by IL-6 expression. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29616104 | PubMed |
| 4 | 29769604 | Macrophage Cytokines Enhance Cell Proliferation of Normal Prostate Epithelial Cells through Activation of ERK and Akt. | Sci Rep | 2018 | https://conductscience.org/library/papers/29769604 | PubMed |
| 5 | 28990062 | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | Mol Med Rep | 2017 | https://conductscience.org/library/papers/28990062 | PubMed |
| 6 | 25559415 | Cancer statistics, 2015. | CA Cancer J Clin | 2015 | https://conductscience.org/library/papers/25559415 | PubMed |
| 7 | 10395330 | Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. | Nat Med | 1999 | https://conductscience.org/library/papers/10395330 | PubMed |
| 8 | 22970210 | Genomic DNA copy-number alterations of the let-7 family in human cancers. | PLoS One | 2012 | https://conductscience.org/library/papers/22970210 | PubMed |
| 9 | 28910332 | Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway. | PLoS One | 2017 | https://conductscience.org/library/papers/28910332 | PubMed |
| 10 | 30015355 | IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma. | J Cell Biochem | 2018 | https://conductscience.org/library/papers/30015355 | PubMed |
| 11 | 15329734 | NF-kappaB functions as a tumour promoter in inflammation-associated cancer. | Nature | 2004 | https://conductscience.org/library/papers/15329734 | PubMed |
| 12 | 24723924 | Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues. | Front Immunol | 2014 | https://conductscience.org/library/papers/24723924 | PubMed |
| 13 | 24205370 | The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context. | PLoS One | 2013 | https://conductscience.org/library/papers/24205370 | PubMed |
| 14 | 25604439 | Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice. | Basic Res Cardiol | 2015 | https://conductscience.org/library/papers/25604439 | PubMed |
| 15 | 20371344 | Macrophage diversity enhances tumor progression and metastasis. | Cell | 2010 | https://conductscience.org/library/papers/20371344 | PubMed |
| 16 | 27157642 | miRNA let-7b modulates macrophage polarization and enhances tumor-associated macrophages to promote angiogenesis and mobility in prostate cancer. | Sci Rep | 2016 | https://conductscience.org/library/papers/27157642 | PubMed |
| 17 | 30480817 | miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30480817 | PubMed |
| 18 | 21355095 | miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. | Blood | 2011 | https://conductscience.org/library/papers/21355095 | PubMed |
| 19 | 31707448 | Suppressors of cytokine signalling (SOCS)-1 inhibits neuroinflammation by regulating ROS and TLR4 in BV2 cells. | Inflamm Res | 2020 | https://conductscience.org/library/papers/31707448 | PubMed |
| 20 | 28258213 | Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway. | J Biol Chem | 2017 | https://conductscience.org/library/papers/28258213 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42695421 | MicroRNA regulation of macrophage polarization in lung cancer: Regulatory networks and therapeutic potential (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/42695421 | PubMed |
| 42244152 | The Research Progress of Tumor-Associated Macrophages in Prostate Cancer. | J Immunol Res | 2026 | https://conductscience.org/library/papers/42244152 | PubMed |
| 41836263 | The role of MiRNA-mediated tumor microenvironment in bone metastasis from a multi-omics perspective: cross-cancer mechanisms and clinical translation. | Front Oncol | 2026 | https://conductscience.org/library/papers/41836263 | PubMed |
| 41764450 | Regulatory roles of microRNAs in signaling pathways and their biomarker potential in prostate cancer. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/41764450 | PubMed |
| 41551936 | Mechanism of Non-Small Cell Lung Cancer-Derived Extracellular Vesicle miRNA hsa-let-7b-5p Targeting AP1S1 to Regulate M2 Macrophage Polarization. | Int J Genomics | 2026 | https://conductscience.org/library/papers/41551936 | PubMed |
| 40635062 | Downregulation of exosomal miR-let-7e-5p induces macrophage M2 polarization by targeting Rictor/AKT1 signal pathway in brucellosis patients. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40635062 | PubMed |
| 40556678 | The role and mechanisms of exosome microRNA in regulating metastasis within the tumor microenvironment of prostate cancer. | Front Oncol | 2025 | https://conductscience.org/library/papers/40556678 | PubMed |
| 40423803 | Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40423803 | PubMed |
| 40279022 | Evaluation of the diagnostic value of a three-miRNA panel in prostate cancer: a discovery and validation study. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40279022 | PubMed |
| 39632081 | Advanced MicroRNA delivery for lung inflammatory therapy: surfactant protein A controls cellular internalisation and degradation of extracellular vesicles. | Thorax | 2025 | https://conductscience.org/library/papers/39632081 | PubMed |
| 39585513 | Role of Chemokines and Cytokines in Prostate Cancer Skeletal Metastasis. | Curr Osteoporos Rep | 2024 | https://conductscience.org/library/papers/39585513 | PubMed |
| 39247145 | Current landscape of exosomal non-coding RNAs in prostate cancer: Modulators and biomarkers. | Noncoding RNA Res | 2024 | https://conductscience.org/library/papers/39247145 | PubMed |
| 39120274 | Selective Enrichment of Angiomirs in Extracellular Vesicles Released from Ischemic Skeletal Muscles: Potential Role in Angiogenesis and Neovascularization. | Cells | 2024 | https://conductscience.org/library/papers/39120274 | PubMed |
| 38361754 | MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway. | Oncol Res | 2024 | https://conductscience.org/library/papers/38361754 | PubMed |
| 37965240 | Genetically engineered M2-like macrophage-derived exosomes for P. gingivalis-suppressed cementum regeneration: From mechanism to therapy. | Bioact Mater | 2024 | https://conductscience.org/library/papers/37965240 | PubMed |
| 37151385 | Endoplasmic Reticulum Stress Promotes Prostate Cancer Cells to Release Exosome and Up-regulate PD-L1 Expression via PI3K/Akt Signaling Pathway in Macrophages. | J Cancer | 2023 | https://conductscience.org/library/papers/37151385 | PubMed |
| 37069162 | Identification and characterization of miRNAs in spleens of sheep subjected to repetitive vaccination. | Sci Rep | 2023 | https://conductscience.org/library/papers/37069162 | PubMed |
| 37019900 | Let-7b-5p inhibits breast cancer cell growth and metastasis via repression of hexokinase 2-mediated aerobic glycolysis. | Cell Death Discov | 2023 | https://conductscience.org/library/papers/37019900 | PubMed |
| 36552765 | CD146+ Endometrial-Derived Mesenchymal Stem/Stromal Cell Subpopulation Possesses Exosomal Secretomes with Strong Immunomodulatory miRNA Attributes. | Cells | 2022 | https://conductscience.org/library/papers/36552765 | PubMed |
| 36506097 | Tamoxifen resistance-related ceRNA network for breast cancer. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/36506097 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33005103
GET https://conductscience.org/api/papers/v1/33005103/references?page=2